1-2 of 2
Iris Isufi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

Open Access
Clinical Trials & Observations
Kirk Cahill, James Godfrey, Chadi Nabhan, Justin Kline, Peter A. Riedell, Kenneth S. Cohen, Sunil Narula, Theodore G. Karrison, Jessica Robertson, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Seung Tae Lee, Jennie Law, Paul A. S. Fishkin, Iris Isufi, Mario Velasco, Lynne Kaminer, Sonali M. Smith
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5665–5675.
https://doi.org/10.1182/bloodadvances.2025017092
Published: 2025
Includes: Supplemental data
Journal Articles

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma

Free
Kunal C. Potnis, Mengyang Di, Iris Isufi, Lohith Gowda, Stuart E. Seropian, Francine M. Foss, Howard P. Forman, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2023) 7 (5): 801–810.
https://doi.org/10.1182/bloodadvances.2022008097
Published: 2023
Includes: Supplemental data